These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18403938)

  • 21. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.
    Merryweather-Clarke AT; Cadet E; Bomford A; Capron D; Viprakasit V; Miller A; McHugh PJ; Chapman RW; Pointon JJ; Wimhurst VL; Livesey KJ; Tanphaichitr V; Rochette J; Robson KJ
    Hum Mol Genet; 2003 Sep; 12(17):2241-7. PubMed ID: 12915468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of genetic haemochromatosis and iron overload in patients attending rheumatology and joint replacement clinics.
    Donnelly SC; Joshi NG; Thorburn D; Cooke A; Reid G; Neilson M; Capell H; Stanley AJ
    Scott Med J; 2010 Feb; 55(1):14-6. PubMed ID: 20218273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the HFE hemochromatosis gene in a community-based population of elderly women.
    Rossi E; Kuek C; Beilby JP; Jeffrey GP; Devine A; Prince RL
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1150-4. PubMed ID: 15377292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase.
    Bhavnani M; Lloyd D; Bhattacharyya A; Marples J; Elton P; Worwood M
    Gut; 2000 May; 46(5):707-10. PubMed ID: 10764716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
    Pedersen P; Milman N
    Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevalence of hemochromatosis-associated mutations in the hemochromatosis gene in the Danish population].
    Larsen LE; Ellervik C; Appleyard M; Nordestgaard BG; Birgens H; Tybjaerg-Hansen A
    Ugeskr Laeger; 2002 Sep; 164(39):4545-7. PubMed ID: 12380399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
    De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
    Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: the modern diagnosis and management of haemochromatosis.
    Adams PC
    Aliment Pharmacol Ther; 2006 Jun; 23(12):1681-91. PubMed ID: 16817911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron overload is rare in patients homozygous for the H63D mutation.
    Kelley M; Joshi N; Xie Y; Borgaonkar M
    Can J Gastroenterol Hepatol; 2014 Apr; 28(4):198-202. PubMed ID: 24729993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary haemochromatosis: diagnosis and management in the gene era.
    Olynyk JK
    Liver; 1999 Apr; 19(2):73-80. PubMed ID: 10220735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemochromatosis and HFE gene.
    Moirand R; Deugnier Y; Brissot P
    Acta Gastroenterol Belg; 1999; 62(4):403-9. PubMed ID: 10692770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examining the clinical use of hemochromatosis genetic testing.
    Lanktree MB; Lanktree BB; Paré G; Waye JS; Sadikovic B; Crowther MA
    Can J Gastroenterol Hepatol; 2015; 29(1):41-5. PubMed ID: 25706573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy.
    De Marco F; Liguori R; Giardina MG; D'Armiento M; Angelucci E; Lucariello A; Morante R; Cimino L; Galeota-Lanza A; Tarantino G; Ascione A; Budillon G; Vecchione R; Martinelli R; Matarazzo M; De Simone V
    Clin Chem Lab Med; 2004 Jan; 42(1):17-24. PubMed ID: 15061375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
    Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
    Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penetrance, cancer incidence and survival in HFE haemochromatosis-A population-based cohort study.
    Schaefer B; Pammer LM; Pfeifer B; Neururer S; Troppmair MR; Panzer M; Wagner S; Pertler E; Gieger C; Kronenberg F; Lamina C; Tilg H; Zoller H
    Liver Int; 2024 Mar; 44(3):838-847. PubMed ID: 38263707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.
    Beutler E; Felitti VJ; Koziol JA; Ho NJ; Gelbart T
    Lancet; 2002 Jan; 359(9302):211-8. PubMed ID: 11812557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A primer for predicting risk of disease in HFE-linked hemochromatosis.
    Adams PC; Walker AP; Acton RT
    Genet Test; 2001; 5(4):311-6. PubMed ID: 11960576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A targeted approach significantly increases the identification rate of patients with undiagnosed haemochromatosis.
    Cadet E; Capron D; Perez AS; Crépin SN; Arlot S; Ducroix JP; Dautréaux M; Fardellone P; Leflon P; Merryweather-Clarke AT; Livesey KJ; Pointon JJ; Rose P; Harcourt J; Emery J; Sueur JM; Feyt R; Robson KJ; Rochette J
    J Intern Med; 2003 Feb; 253(2):217-24. PubMed ID: 12542563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls.
    Byrnes V; Ryan E; O'Keane C; Crowe J
    Blood Cells Mol Dis; 2000 Feb; 26(1):2-8. PubMed ID: 10772870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is HFE haemochromatosis?
    Marjot T; Collier J; Ryan JD
    Br J Hosp Med (Lond); 2016 Jun; 77(6):C91-5. PubMed ID: 27269766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.